senicapoc has been researched along with Colitis Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansen, TP; Kjeldsen, J; Klinge, L; Knudsen, T; Koch Hansen, L; Köhler, R; Larsen, D; Rabjerg, M; Sevelsted-Møller, L; Wulff, H | 1 |
1 other study(ies) available for senicapoc and Colitis Gravis
| Article | Year |
|---|---|
Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
Topics: Acetamides; Adult; Biomarkers; Case-Control Studies; CD3 Complex; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Colitis, Ulcerative; Cross-Sectional Studies; Female; Gene Expression; Humans; Interferon-gamma; Interleukin-17; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Kv1.3 Potassium Channel; Lymphocytes; Male; Middle Aged; Receptors, IgG; RNA, Messenger; Severity of Illness Index; Trityl Compounds; Tumor Necrosis Factor-alpha | 2014 |